chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shortly after the injection in the deltoid bicep began to swell; less than 1 year of child was given Fluzone High-Dose Quadrivalent; Initial information received on 22-Jul-2022 regarding an unsolicited valid non-serious case received from a pharmacist via call center.  This case involves a less than 1 year old child with unknown gender who was given Influenza Quadrival A-B High Dose Hv Vaccine [Fluzone High-Dose Quadrivalent] and shortly after the injection in the deltoid bicep began to swell.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On unknown date in November 2020, the patient received a dose of 0.7 mL (millimeter) of suspect Influenza Quadrival A-B High Dose Hv Vaccine once (lot number, strength, formulation and expiry date not reported) via intramuscular route in unknown administration site for immunization.  It was reported that the less than less than 1 year of child was given Fluzone High-Dose Quadrivalent (product administered to patient of inappropriate age) (onset: Nov-2020, latency: same day). Further reported that shortly after the injection in the deltoid bicep began to swell (vaccination site swelling) (onset: 2020, latency: unknown)  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for event (vaccination site swelling).  At time of reporting, the outcome was Unknown for both events.
He is miserable today; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (He is miserable today) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, the patient experienced FEELING ABNORMAL (He is miserable today). At the time of the report, FEELING ABNORMAL (He is miserable today) outcome was unknown.            No concomitant medications were reported.  No treatment was reported.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 16-JAN-2012 at 7:30 and on 17-JAN-2012 at 7:30, ZOSTAVAX (Lot # 671141/1267AA) was exposed to -8 degrees C for an estimated total time out of range of 14 hours. On 22-FEB-2012, the patient was vaccinated with an out of range dose of ZOSTAVAX (Lot # 671141/1267AA, expiration date 05-NOV-2012) (dose and route of administration were not provided). No adverse experience was reported. This is one of 182 reports received from the same source. Additional information has been requested.
Wheezing, ugly cough, no phlegm.  Began two weeks after 1st vaccination, lasting until now (22 March, 2021) and who knows when it will subside?
Initial report was received from a health care professional on 24 May 2012. An 18-year-old female patient had received a dose two intramuscular injection of MENACTRA, Sanofi Pasteur Inc., lot number U3906AA, (site not reported) on 23 May 2012. The next day on 24 May 2012, the patient experienced a fever of 101.9 degrees Fahrenheit (F), nausea, vomiting and disequilibrium. The patient had no illness at the time of vaccination and no past medical history. No further information was available at the time of the report. The patient's out come was not recovered. Documents held by sender: None.
myocarditis; Numb left arm and numb left leg; chest pain/Experienced very intense chest pain for some time; very intense heartburn; acid reflux; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 27-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 27 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "depression" (unspecified if ongoing); "mood disorders" (unspecified if ongoing). The patient had no known allergy. Concomitant medication(s) included: PROBIOTICS. Vaccination history included: pfizer-biontech (Dose Number: 1, Batch/Lot No: ER8732, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 02Apr2021, when the patient was 24-year-old, for COVID-19 Immunization; pfizer-biontech (Dose Number: 2, Batch/Lot No: EW0176, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 23Apr2021, when the patient was 24-year-old, for COVID-19 Immunization; Pfizer-biontech (Dose Number: 3, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left, Route of Administration: Intramuscular), for COVID-19 Immunization. The following information was reported: MYOCARDITIS (medically significant), outcome "recovered with sequelae"; HYPOAESTHESIA (non-serious) with onset the same day of vaccination, outcome "recovered with sequelae", described as "Numb left arm and numb left leg"; CHEST PAIN (non-serious) with onset the same day of vaccination, outcome "recovered with sequelae", described as "chest pain/Experienced very intense chest pain for some time"; DYSPEPSIA (non-serious), outcome "recovered with sequelae", described as "very intense heartburn"; GASTROOESOPHAGEAL REFLUX DISEASE (non-serious), outcome "recovered with sequelae", described as "acid reflux". The events "myocarditis", "numb left arm and numb left leg", "chest pain/experienced very intense chest pain for some time", "very intense heartburn" and "acid reflux" required physician office visit. Day after vaccination, the patient went to doctor that said symptoms were consistent with myocarditis. The patient experienced very intense chest pain for some time after booster was administered patient experienced very intense heartburn and acid reflux that they previously never had. Patient said chest pain symptoms will come and go moderately now.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
I developed Covid-19 related symptoms the day after my second dose. I tested and the result was that I am Cocid-19 positive .
This spontaneous report as received from a consumer via Clinic refers to a currently 4 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 07-SEP-2017, the patient was vaccinated with improperly stored dose of M-M-R II, recombinant human albumin (rHA) 1 dose unit (lot # M044350, Expiry date was not reported) for prophylaxis (product storage error). There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1801USA000166:
Initially after first vaccination, there was soreness at injection site but no fever or other symptoms were experienced and soreness resolved after 3 days.  Seven days after initial vaccination, the  area of injection is red and became extremely itchy. There is also a palpable lump the size of a half-dollar under the skin and the skin is warm and red. There is no drainage. I have a temp of 98.9 ?I usually run low at 97.6.
Generalized papular rash, nausea, vomiting and fever of 102.5F. Treatment of symptoms; Tylenol for fever.
12/19/07 Face was red.  Felt fatigued. That night scapl started tingling. Today 12/20/07 red bumpy rash starting midline on forehead at hair line, extending to above ear on right side. Rash and swelling also under right eye.  Feeling of pin and needles in area of rash..
No adverse effects reported; patient was inadvertently administered an expired dose of VARIVAX; This spontaneous report was received from a registered nurse referring to a 15-month-old patient of unknown gender. The patient's pertinent medical history, historical drug, current conditions, concomitant medication and drug reactions or allergies were not reported.     On 20-MAY-2020, the patient was inadvertently vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot number R011807, which was verified to be a valid one, and expiration date on 23-APR-2020 (strength, dose, vaccination scheme, anatomical location and route of administration were not provided), as prophylaxis (expired product administered); which was reconstituted with a sterile diluent (MERCK STERILE DILUENT). No adverse effects reported.
Began screaming @ 3PM, continuing for 2 hrs; slept 2 1/2 hrs & wakened screaming until 1AM; slept for 1 hr, waking @ 2AM screamed until noon; afebrile; no vomiting; 2 loose stools;
ankle swelling; sick; back pain; back pain extending down to his legs; painful breathing; This case was reported by a pharmacist via call center representative and described the occurrence of back pain in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number 7447A, expiry date 25th April 2020) for prophylaxis.   The patient's past medical history included chickenpox (as a child).   On 16th April 2019, the patient received the 1st dose of Shingrix. On 16th April 2019, less than a day after receiving Shingrix, the patient experienced back pain, leg pain and painful respiration. On 18th April 2019, the patient experienced sickness. On 22nd April 2019, the patient experienced ankle swelling. On an unknown date, the outcome of the back pain, leg pain, painful respiration, ankle swelling and sickness were unknown.   It was unknown if the reporter considered the back pain, leg pain, painful respiration, ankle swelling and sickness to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that the patient experienced back pain extending down to his legs, painful breathing unrelated to anaphylaxis, and ankle swelling after 1st dose of Shingrix vaccination. On 17th April 2019, the patient went to work but called in sick on 18th April 2019. The pharmacist stated she saw the patient's left ankle swollen on 22nd April 2019.
Patient complained of dizzy spells, and fainted. He bit his tongue while experiencing a possible seizure. No prior history of seizure disorder. Parent was called right after the student experienced adverse reaction. Vital signs taken B/P 128/88, Pulse - 80, Pulse oximetry - 99 %, temperature was 97.4. Patient had not prior history of COVID-19, not taking any medications, no hypertension. Patient became alert  30 seconds afterwards.
Pain in arm and shoulder (still ongoing as of 10/15/2014); Severe chills on 10/16/2014 about 6:00 PM.
Worsening of menstrual cycle intensity and length; Worsening of menstrual cycle intensity and length; Worsening of menstrual cycle intensity and length; worsening of asthma symptoms; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Mar2021 (Lot number: EN6207) at the age of 35 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Exercise induced asthma" (unspecified if ongoing); "ventricular bigeminy" (unspecified if ongoing). Concomitant medication(s) included: TYLENOL. Past drug history included: Diflucan, reaction(s): "Drug allergy". The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious), MENSTRUAL DISORDER (non-serious), CONDITION AGGRAVATED (non-serious) all with onset 22Mar2021, outcome "not recovered" and all described as "Worsening of menstrual cycle intensity and length"; ASTHMA (non-serious) with onset 22Mar2021, outcome "not recovered", described as "worsening of asthma symptoms". The events "worsening of menstrual cycle intensity and length", "worsening of menstrual cycle intensity and length", "worsening of menstrual cycle intensity and length" and "worsening of asthma symptoms" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of heavy menstrual bleeding, menstrual disorder, condition aggravated. Therapeutic measures were taken as a result of asthma.  Additional Information: Worsening of menstrual cycle intensity and length, worsening of asthma symptoms resulting in more frequent use of albuterol inhaler that was otherwise rarely needed. Patient haven't been on other vaccine in four weeks. Patient hasn't been tested Covid prior vaccination. Patient hasn't been tested Covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Patient received 0.5 mg instead of the booster dose of 0.25 mg
Hives the night of 3/13.   Queasy and hot within 15 min of injection Headache within the hour of injection. Bruising of arm and sore arm in the days that followed 3/13 Fatigue 3/14 and 3/15 "covid arm" appeared on 3/14 at 9pm PST measuring approx 6 inches by 3 inches / welt, raised skin, hot to touch.
swelling & pain to let axilla;rabies ID given to lt deltoid area lasted one day
Moderately severe dizziness and nausea; Moderately severe dizziness and nausea; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration at left leg on 19Feb2021 14:00 at single dose for COVID-19 immunization. The patient had allergies to fermented, mold producing foods: cheese, mushrooms and yeast. The patient had other medical history including osteoporosis, hypothyroidism and asthma. The patient is not pregnant.  No other vaccine in four weeks. Concomitant medications (medications in two weeks) included levothyroxine and liothirinine. The patient previously received the first dose of BNT162B2 on 20Jan2021 15:00 for COVID-19 immunization. On day four following the second vaccine, on 23Feb2021 10:00, the patient experienced moderately severe dizziness and nausea. She could not move or walk without feeling extremely nauseous and dizzy. There was no treatment for the events. The events were assessed as serious medically significant by reporter. The patient had no COVID prior vaccination and not COVID tested post vaccination. The patient was recovering from the events.   Information on lot /batch number has been requested.
This spontaneous report as received from a physician via a company representative refers to a 15 year old female patient with penicillin allergy. On 28-AUG-2015, the patient was vaccinated with the first dose of GARDASIL lot # K010215 exp. 05-MAY-2015 in the deltoid. Concomitant therapies included ZYRTEC. In 2015, after administration of GARDASIL, the patient experienced menstruation delayed as she missed menstruation which was abnormal for her. On 02-NOV-2015, the patient received the second dose of GARDASIL (same lot number). Then 2 days later on 04-NOV-2015, the patient experienced a severe headache. The resolution of the patient's headache had not been verified at this time. The patient received treatment with ibuprofen 400mg 4x per day. No lab diagnostics studies were performed. It was not verified if the patient plans to continue the three dose series of GARDASIL but the physician stated that it was "unlikely" that she would be administered her third and final dose of the GARDASIL series. The outcome of menstruation delayed and headache was unknown. Additional information has been requested.
Fever - rash all over the body, especially arms, legs, torso.  Rash was raised with target lesions, some coalescent, with color changing from slight pink to purplish.  Erythema multiforme.
sore arm, with a little pain for 12 hours; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm, with a little pain for 12 hours) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm, with a little pain for 12 hours). On 21-Mar-2021, PAIN IN EXTREMITY (sore arm, with a little pain for 12 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications provided.. No treatment medications provided   This case was linked to MOD-2021-118385 (Patient Link).
I got on 05/11/2022. I had a cough, scratchy throat and a fever. It was a mild case. I had be quarantine for about 6 days. My doctor call me Paxlovid for 5 days and I took my last one today. I am feeling fine as of today.
Large (5 cm x 5 cm) localized reaction-right deltoid 2 hr after Varicella vaccine
shingles on the right lower back down and around to his groin; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles on the right lower back down and around to his groin) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced HERPES ZOSTER (shingles on the right lower back down and around to his groin). At the time of the report, HERPES ZOSTER (shingles on the right lower back down and around to his groin) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication were reported.  No treatment medication were reported.
1 week after vaccine I had an extremely heavy menstrual cycle lasting 2 days.  This was heavier and shorter than usual.  Since then, I have not had my period.  It's now been 7 months.
Within 15 minutes of receiving my J&J vaccine, I experienced diarrhea. 12 hours later I ran a temperature of 37.5 and also had chills. On Sunday morning 04-11-2021, I had horribleheadaches and I took a Tylenol but it did not help. On Monday, Tuesday and Wednesday I again woke up with headaches and I felt extremely fatigued. I went to see my PCP who performed blood tests and also did a D-dimme test which the tests came back as being okay. I also experienced a full body rash and was having slight breathing issues. I also went to see an allergist on Monday 04-12-2021 due to my whole body rash, patchy skin, red and white bumps on my forehead. I was also concerned because at the inside of my mouth and upper pallet I had red bumps which lasted three days. I took me a whole week to recover from these symptoms.
fell like a ton of bricks; felt off balance; damaged rotary cuff in the right shoulder; damaged AC joint in the right shoulder; This spontaneous case was reported by a nurse and describes the occurrence of FALL (fell like a ton of bricks), BALANCE DISORDER (felt off balance), ROTATOR CUFF SYNDROME (damaged rotary cuff in the right shoulder) and JOINT INJURY (damaged AC joint in the right shoulder) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced FALL (fell like a ton of bricks), BALANCE DISORDER (felt off balance), ROTATOR CUFF SYNDROME (damaged rotary cuff in the right shoulder) and JOINT INJURY (damaged AC joint in the right shoulder). The patient was treated with CORTISONE at an unspecified dose and frequency; GABAPENTIN (NEURONTIN) at an unspecified dose and frequency and TRAMADOL HYDROCHLORIDE (TRAMACET [TRAMADOL HYDROCHLORIDE]) for Discomfort, at an unspecified dose and frequency. At the time of the report, FALL (fell like a ton of bricks), BALANCE DISORDER (felt off balance), ROTATOR CUFF SYNDROME (damaged rotary cuff in the right shoulder) and JOINT INJURY (damaged AC joint in the right shoulder) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter.   This case was linked to MOD-2021-033543 (Patient Link).
Tinnitus (ringing) L ear starting shortly after 2nd dose. Duration is constant.
Fever spiked to 100° briefly, Night Sweats every night for a week, Achy joints worse day 5/2 but still ongoing, better each day.
Severe headache/migraine started 7 days after both vaccines. Symptoms were severe throbbing/pressure behind right eye and radiating throughout head, Headache/migraine lasted approximately 24-36hrs. No prior history of migraines.
Feel like I have a cold; Slight runny nose; More fatigue than anything else; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Jul-2021 and was forwarded to Moderna on 24-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Feel like I have a cold), RHINORRHOEA (Slight runny nose) and FATIGUE (More fatigue than anything else) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Feel like I have a cold), RHINORRHOEA (Slight runny nose) and FATIGUE (More fatigue than anything else). At the time of the report, NASOPHARYNGITIS (Feel like I have a cold), RHINORRHOEA (Slight runny nose) and FATIGUE (More fatigue than anything else) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicines was not reported by reporter   Treatment information was not provided
Onset of hemmoragic oral bullae after eating  very hot cheese toast 1-20-2021  Widely scattered petechiae lower and upper extremeties 1-21-2021 Extensive petechaie lower extremities and a few on trunk face 1-22-2021 CBC in ER showed severe thrombocytomenia with platelets less than 2000 1-22-2021 Admitteed and treated with Decadron 40 mg IV, and IVIG infusions once daily Jan. 23rd and 24th 2021 Hepatiitis pannel negative EBV negative, COVID Nasopharengeal negative, splenic U/S upper limit of normal but unchanged on comparison with old imaging. With treatment platlets increased to 65,000, Discharged from hospital.  IVIG discontinued Oral decadron 40mg will continue for 2 days with CBC hematology f/u in 36 hours